A regulatory governance perspective on Health Technology Assessment (HTA) in Sweden

Health Policy

Volumn 116, Issue 1, 2014, Pages 27-36

  Shah, Sara Mehmood Birchall ^a   Barron, Anthony ^a   Klinger, Corinna ^b   Wright, John S F ^a  

^a LONDON SCHOOL OF ECONOMICS   (United Kingdom)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

European Union; Health Technology Assessment; Healthcare; Regulation; Sweden

Indexed keywords

ARTICLE; AUTHORITY; DECISION MAKING; GOVERNMENT; HEALTH CARE QUALITY; HEALTH SERVICE; HEALTH TECHNOLOGY ASSESSMENT; HUMAN; INTERVIEW; MEDICAL TECHNOLOGY; ORGANIZATIONAL STRUCTURE; RESEARCH; RESPONSIBILITY; SWEDEN; BIOMEDICAL TECHNOLOGY ASSESSMENT; GOVERNMENT REGULATION; HEALTH CARE POLICY; LEGISLATION AND JURISPRUDENCE;

BIOMEDICAL TECHNOLOGY; GOVERNMENT REGULATION; HEALTH POLICY; HUMANS; SWEDEN; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 84898905400     PISSN: 01688510     EISSN: 18726054     Source Type: Journal    
DOI: 10.1016/j.healthpol.2014.02.014     Document Type: Article

References (57)

1. World Health Organization The World Health Report 2000 - health systems: improving performance 2000, WHO, Geneva.
2. Marmor T., Okma K.G.H. Review essay: health care systems in transition. Journal of Health Politics, Policy and Law 2003, 28:747-755.
3. Marmor T., Freeman R., Okma K. Comparative perspectives and policy learning in the world of health care. Journal of Comparative Policy Analysis: Research and Practice 2005, 7:331-348.
4. Saltman R.B. The role of comparative health studies for policy learning. Health Economics, Policy, and Law 2012, 7:11-13.
5. Marmor T. The unwritten rules of cross-national policy analysis. Health Economics, Policy, and Law 2012, 7:19-20.
6. Tuohy C.H. Shall we dance? The intricate project of comparison in the study of health policy. Health Economics, Policy, and Law 2012, 7:21-23.
7. Morgan S.G., McMahon M., Mitton C., Roughead E., Kirk R., Kanavos P., et al. Centralized drug review processes in Australia, Canada, New Zealand, and the United Kingdom. Health Affairs 2006, 25:337-347.
8. Sorensen C., Drummond M., Kanavos P. Ensuring value for money in health care the role of Health Technology Assessment in the European Union 2008, The European Observatory on Health Systems and Policies, Cornwall.
9. Sorenson C., Drummond M., Kristensen F.B., Busse R. How can the impact of Health Technology Assessment be enhanced? 2008, WHO Regional Office for Europe, Copenhagen.
10. Chalkidou K. Comparative effectiveness review within the U.K.'s National Institute for Health and Clinical Excellence 2009, The Commonwealth Fund, New York.
11. Chalkidou K., Tunis S., Lopert R., Rochaix L., Sawicki P.T., Nasser M., et al. Comparative effectiveness research and evidence-based health policy: experience from four countries. The Milbank Quarterly 2009, 87:339-367.
12. Kanavos P., Nicod E., van den Aardweg S., Pomedli S. The impact of health technology assessments: an international comparison. EuroObserver 2010, 12:1-6.
13. Sorenson C., Chalkidou K. Reflections on the evolution of Health Technology Assessment in Europe. Health Economics, Policy and Law 2012, 7:25-45.
14. Dickson M., Hurst J., Jacobzone S. Survey of pharmacoeconomic assessment activity in eleven countries. OECD health working paper no. 4 2003, Organisation for Economic Co-Operation and Development.
15. Draborg E., Andersen C.K. What influences the choice of assessment methods in health technology assessments? Statistical analysis of international health technology assessments from 1989 to 2002. International Journal of Technology Assessment in Health Care 2006, 22:19-25.
16. Hutton J., Trueman P., Facey K. Harmonization of evidence requirements for Health Technology Assessment in reimbursement decision making. International Journal of Technology Assessment in Health Care 2008, 24:511-517.
17. Kristensen F.B. EUnetHTA and health policy-making in Europe. Eurohealth 2006, 12(1):36-38.
18. Kristensen F.B. Transnational collaboration on Health Technology Assessment - a political priority in Europe. Health Technology Assessment and health policy-making in Europe - current status, challenges and potential 2008, Word Health Organization, Geneva. M.V. Garrido, F.B. Kristensen, C.P. Nielsen, R. Busse (Eds.).
19. Lothgren M., Ratcliffe M. Pharmaceutical industry's perspective on Health Technology Assessment. International Journal of Technology Assessment in Health Care 2004, 20:97-101.
20. Turner S., Chase D.L., Milne R., Cook A., Hicks N.J., Rosten C., et al. The Health Technology Assessment adaptation toolkit: description and use. International Journal of Technology Assessment in Health Care 2009, 25(Suppl. 2):37-41.
21. Drummond M.F. Will there ever be a European drug pricing and reimbursement agency?. The European Journal of Health Economics 2003, 4:67-69.
22. Sorenson C., Huseyin N., Cylus J. Evidence of comparative efficacy should have a formal role in European drug approvals. British Medical Journal 2011, 343:48-49.
23. European Parliament and the Council of the European Union Directive 2011/24/EU on the application of patients' rights in cross-border healthcare 2011.
24. Klinger C., Shah S.M.B., Barron A.B., Wright J.S.F. Regulatory space and the contextual mediation of common functional pressures: analyzing the factors that led to the German Efficiency Frontier approach. Health Policy 2013, 109:270-280.
25. Wright J.S.F., Barron A.B., Klingler C., Shah S.M.B. A regulatory governance perspective on Health Technology Assessment (HTA) in England and Germany. Global Policy 2014, forthcoming.
26. Stevens A.J., Milne R. Health Technology Assessment in England and Wales. International Journal of Technology Assessment in Health Care 2004, 20(1):11-24.
27. Hancher L., Moran M. Organizing regulatory space. Capitalism, culture and regulation 1989, Clarendon Press, Oxford. L. Hancher, M. Moran (Eds.).
28. Scott C. Analysing regulatory space: fragmented resources and institutional design. Public Law 2001, (Summer):329-353. ISSN 0033-3565.
29. Thatcher M., Coen D. Reshaping european regulatory space: an evolutionary analysis. West European Politics 2008, 31:806-836.
30. Levi-Faur D. Varieties of regulatory capitalism: sectors and nations in the making of a new global order. Governance 2006, 19(3):363-366.
31. Levi-Faur D. Regulatory capitalism: the dynamics of change beyond telecoms and electricity. Governance 2006, 19(3):497-525.
32. Braithwaite J., Drahos P. Global business regulation 2000, Cambridge University Press, Cambridge.
33. Wright J.S.F. Regulatory capitalism and the UK Labour Government's re-regulation of commissioning in the English National Health Service. Law and Policy 2011, 33(1):27-59.
34. Young J.J. Outlining regulatory space: agenda issues and the FASB. Accounting, Organizations and Society 1994, 19(1):83-109.
35. Barron A., Klinger C., Shah S.M.B., Wright J.S.F. A Regulatory Governance Perspective on Health Technology Assessment (HTA) in France: The Contextual Mediation of Common Functional Pressures 2014, forthcoming.
36. Burris S. Governance, micro-governance and health. Temple Law Review 2004, 77:335-361.
37. Gunningham N., Grabosky P., Sinclair D. Smart regulation: designing environmental policy 1998, Oxford University Press, Oxford.
38. Wright J.S.F., Head B. Reconsidering regulation and governance theory: a learning approach. Law & Policy 2009, 31:192-216.
39. Glenngård A.H., Hjalte F., Svensson M., Anell A., Bankauskaite V. Health systems in transition: Sweden 2005, WHO Regional Office for Europe on behalf of the European Observatory on Health Systems and Policies, Copenhagen, Available online at: http://www.euro.who.int/en/who-we-are/partners/observatory/health-systems-in-transition-hit-series/countries-and-subregions/sweden-hit-2005.
40. Anell A., Glenngård A.H., Merkur S. Sweden: health system review. Health Systems in Transition 2012, 14(5):1-159. Available online at: http://www.euro.who.int/en/who-we-are/partners/observatory/health-systems-in-transition-hit-series/countries-and-subregions/sweden-hit-2012.
41. National Board of Health and Welfare The Swedish National Board of Health and Welfare - a presentation 2011, Available from: www.socialstyrelsen.se/english.
42. National Board of Health and Welfare National guidelines 2011, [cited 2011 November 12]. Available from: http://www.socialstyrelsen.se/nationalguidelines.
43. Carlsson P. Health Technology Assessment and priority setting for health policy in Sweden. International Journal of Technology Assessment in Health Care 2004, 20(1):44-54.
44. Medical Products Agency Swedish Medical Products Agency - a centre of regulatory excellence 2005, Available at: http://www.lakemedelsverket.se/upload/om-lakemedelsverket/organisation/lakemedelsverket_broschyr_en.pdf.
45. Pharmaceutical Benefits Board The Swedish pharmaceutical reimbursement system 2007, Pharmaceutical Benefits Board, Solna.
46. Pharmaceutical Benefits Board Cost-effective pharmaceuticals [Swedish] 2007, Pharmaceutical Benefits Board, Solna.
47. Dental and Pharmaceutical Benefits Agency The dental and pharmaceutical benefits agency 2009, Pharmaceutical Benefits Board, Solna.
48. Jonsson E. History of Health Technology Assessment in Sweden. International Journal of Technology Assessment in Health Care 2009, 25(Suppl. 1):42-52.
49. Anell A., Persson U. Reimbursement and clinical guidance for pharmaceuticals in Sweden. Do health-economic evaluations support decision making?. European Journal of Health Economics 2005, 50:274-279.
50. Jonsson E. Health Technology Assessment and comparative effectiveness in Sweden. Value Health 2010, 13(Suppl. 1):6-7.
51. Health Technology Assessment and health policy-making in Europe. Current status, challenges and potential 2008, The European Observatory on Health Systems and Policies, Copenhagen. M.V. Garrido, F.B. Kristensen, C.P. Nielsen, R. Busse (Eds.).
52. Liberati A., Sheldon T.A., Banta H.D. EUR-ASSESS Project Subgroup report on Methodology. Methodological guidance for the conduct of Health Technology Assessment. International Journal of Technology Assessment in Health Care 1997, 13(2):186-219.
53. Busse R., Orvain J., Velasco M., Perleth M., Drummond M., Gartner F. Best practice in undertaking and reporting health technology assessments. International Journal of Technology Assessment in Health Care 2002, 18(2):361-422.
54. Chinitz D. Health Technology Assessment in four countries: response from political science. International Journal of Technology Assessment in Health Care 2004, 20:55-60.
55. Region Västra Götaland HTA-centrum 2011, Available from: http://www.sahlgrenska.se/sv/SU/Forskning/HTA-centrum/.
56. Zethraeus N. Health Technology Assessment (HTA) och ekonomisk utvärdering av hälso- och sjukvårdens metoder (Swedish) 2009, Karolinska Institutets folkhälsoakademi, Stockholm, Available online at: http://www.folkhalsoguiden.se/upload/folkhälsoarbete/Health%20Technology%20Assessment%20(HTA).pdf.
57. Stevens A.J., Longson C. At the Center of Health Care Policy Making: The Use of Health Technology Assessment at NICE. Medical Decision Making 2013, 33(3):320-324.